TOGETHER, TRANSFORMING LIVES
Can Do MS delivers health and wellness education programs to help families living with MS thrive.
Strengthen Families With MS
100% of your gift helps bring life-changing education programs to families in need.
BrainStorm Cell Therapeutics Inc. announced that the U.S. Food and Drug Administration has accepted the Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of NurOwn® for the treatment of progressive multiple sclerosis.+
Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis
Diroximel fumarate was designed to provide patients with relapsing forms of multiple sclerosis a novel oral fumarate with a differentiated profile. The data encompassed in the regulatory package underscore diroximel fumarate’s potential to be a meaningful, new treatment option for the MS community.+
This is the 10th time that Can Do MS has earned a 4-star rating from Charity Navigator, showing the organization uses donor dollars in a fiscally responsible way to further its mission of delivering health and wellness education programs that help families with MS thrive.+
Recently, Can Do MS had the chance to chat with reality star and television personality, Jack Osbourne. Jack is 33 years-old, father of three, and has been living with MS for 5 years. After his diagnosis, Jack partnered with Teva Neuroscience to create the web series You Don’t Know Jack About MS.+